Wenatchee Valley Medical Center Wenatchee Valley — Wenatchee, Washington

Wenatchee Valley Medical Center Wenatchee Valley is a clinical research site located in Wenatchee, Washington, United States 98801.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Wenatchee Valley Medical Center Wenatchee Valley has participated in 3 clinical trials.

Therapeutic areas: Tumors With CDK4/6 Pathway Activation, Tumor Pathway Activations Inhibited by Dovitinib, Metastatic Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wenatchee

Browse all research sites in Washington · View every site in Wenatchee

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wenatchee Valley Medical Center Wenatchee Valley?

Wenatchee Valley Medical Center Wenatchee Valley has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wenatchee Valley Medical Center Wenatchee Valley conducted?

Wenatchee Valley Medical Center Wenatchee Valley has 3 clinical trials on record. Their work covers Tumors With CDK4/6 Pathway Activation, Tumor Pathway Activations Inhibited by Dovitinib, Metastatic Breast Cancer.

Is Wenatchee Valley Medical Center Wenatchee Valley accredited by Crixeo Clinical Trials?

Wenatchee Valley Medical Center Wenatchee Valley has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Wenatchee Valley Medical Center Wenatchee Valley?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.